Uncategorized
Alimera reports 188% increase in net revenue in third quarter
Alimera Sciences reported $6.9 million in net revenue in the third quarter, a 188% increase compared with $2.4 million reported in the same quarter of 2014, according to a press release. The increase was primarily attributed to the launch of Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg) in the U.S.